ABT — ABBOTT LABORATORIES
Index member: S&P 500
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Fundamentals (SEC EDGAR XBRL)
Financials from SEC company facts, point-in-time aligned to each figure’s EDGAR filing date. · Valuation as of 2026-11-18
| Revenue TTM | Revenue YoY | Net income TTM | Net income YoY | ROE (TTM) | Gross margin | Net margin | P/E (TTM) | P/E pct | P/B | P/B pct |
|---|---|---|---|---|---|---|---|---|---|---|
| $48.2B | +10.0% | $4.7B | -66.4% | 9.2% | — | 7.1% | 38.5 | 99% | 3.5 | 16% |
Revenue YoY trend Net margin trend
Wall Street Analyst Consensus
Ratings, 12-month price target and EPS forecasts from the Nasdaq public analyst feed. · Fetched 2026-11-19
| Fiscal quarter end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 1.64 | 16.0× | 1.65 | 1.63 | 8 | +1−4 |
| Mar 2027 | 1.23 | 21.3× | 1.25 | 1.21 | 5 | −4 |
| Jun 2027 | 1.44 | 18.2× | 1.47 | 1.42 | 5 | +1 |
| Sep 2027 | 1.54 | 17.0× | 1.59 | 1.51 | 5 | — |
| Dec 2027 | 1.72 | 15.2× | 1.78 | 1.66 | 5 | +2 |
| Fiscal year end | Consensus EPS forecast | Forward P/E | High EPS | Low EPS | # estimates | Revisions (4wk up/down) |
|---|---|---|---|---|---|---|
| Dec 2026 | 5.52 | 19.0× | 5.53 | 5.50 | 11 | +2−7 |
| Dec 2027 | 5.92 | 17.7× | 6.05 | 5.89 | 11 | −11 |
| Dec 2028 | 6.50 | 16.1× | 6.60 | 6.42 | 5 | — |
| Dec 2029 | 7.08 | 14.8× | 7.23 | 6.97 | 3 | — |
Forward P/E uses the fetch-time price divided by consensus EPS (quarter annualised ×4). Revision score = (upgrades − downgrades) / estimates, from Nasdaq 4-week counts. Source: Nasdaq analyst data
Last updated: 2026-11-21 · Source: SEC EDGAR Form 13F-HR
As of Q3 2026, 3054 SEC-registered investment managers reported holding ABT (ABBOTT LABORATORIES) in their latest 13F filings, with a combined reported value of $136.86B across 1.38B shares. That is +1.0% by share count (+12.65M shares) versus the previous quarter, while reported value moved +12.1%. Ownership is concentrated: the five largest holders account for 33.3% of reported value and the top ten for 48.6%.
Compared with the prior quarter, 231 opened new positions, 1086 added to existing stakes, 1063 trimmed, 210 exited entirely. 13F holdings are quarter-end snapshots, so these moves reflect positioning as of Q3 2026, not real-time trading.
Major shareholders of ABBOTT LABORATORIES (ABT) include Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, ranked by reported 13F value among the 4195 institutional holders on this page.
ABT is a constituent of the S&P 500 and is classified in the Health Care sector.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Legendary Investors Holding ABT
The superinvestors we track who report ABT in their latest 13F filing — each shown at that manager’s own most recent quarter.
| Investor | Quarter | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|---|
|
|
Q3 2026 | 836.79K | $82.70M | 4.54% | Hold |
|
|
Q3 2026 | 766.95K | $75.80M | 2.38% | Reduce |
|
|
Q3 2026 | 735.12K | $72.65M | 0.67% | Add |
|
|
Q3 2026 | 52.80K | $5.22M | 0.43% | Add |
|
|
Q3 2026 | 17.32K | $1.71M | 0.00% | Hold |
|
|
Q3 2026 | 11.51K | $1.14M | 0.02% | Hold |
|
|
Q3 2026 | 2.95K | $291.68K | 0.00% | Reduce |
Which stocks do these investors own together? → · Embed this widget →
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2026 | 3054 | 1.38B | $136.86B | +1.5% |
| Q2 2026 | 3022 | 1.43B | $127.75B | +6.2% |
| Q1 2026 | 3142 | 1.30B | $131.68B | -10.0% |
| Q4 2025 | 3282 | 1.46B | $175.81B | +5.0% |
| Q3 2025 | 3113 | 1.38B | $182.29B | +0.3% |
| Q2 2025 | 3082 | 1.37B | $185.12B | -0.3% |
| Q1 2025 | 3043 | 1.38B | $182.67B | +1.5% |
| Q4 2024 | 2904 | 1.35B | $152.34B | +1.2% |
Over the 8 quarters shown, institutional share counts increased 3% in aggregate (Q4 2024 → Q3 2026); the largest single-quarter swing was Q1 2026 (-10.0%).
Top Institutional Holders (Q3 2026) — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 151.67M | $14.99B | 0.33% | Reduce | |
| 113.25M | $11.19B | 0.23% | Hold | |
| 81.43M | $8.05B | 0.24% | Add | |
| 57.16M | $5.65B | 0.73% | Reduce | |
| 57.16M | $5.65B | 0.73% | Reduce | |
| 47.94M | $4.74B | 0.21% | Reduce | |
| 44.98M | $4.45B | 0.64% | Add | |
| 44.98M | $4.45B | 0.64% | Add | |
| 39.59M | $3.89B | 0.20% | Add | |
| 35.46M | $3.51B | 0.73% | Add | |
| 28.95M | $2.86B | 0.15% | Add | |
| 20.44M | $2.36B | 0.54% | Add | |
| 23.55M | $2.33B | 0.23% | Add | |
| 23.55M | $2.33B | 0.23% | Add | |
| 18.57M | $1.84B | 0.12% | Add | |
| 17.98M | $1.78B | 0.21% | Reduce | |
| 17.69M | $1.75B | 0.53% | Add | |
| 14.93M | $1.48B | 0.50% | Add | |
| 14.40M | $1.42B | 0.07% | Add | |
| 13.59M | $1.34B | 0.94% | Hold | |
| 13.47M | $1.33B | 0.57% | Add | |
| 11.85M | $1.17B | 0.24% | Reduce | |
| 10.62M | $1.05B | 0.09% | Add | |
| 10.10M | $998.29M | 0.24% | Add | |
| 9.85M | $973.10M | 0.21% | Reduce |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2026 — 25 funds
Q1 2026 — 25 funds
Q4 2025 — 25 funds
Q3 2025 — 25 funds
Q2 2025 — 25 funds
New Positions (Q3 2026)
- Polar Capital Holdings Plc 1.49M sh · $147.19M
- Castle Hook Partners LP 981.78K sh · $97.03M
- ORBIMED ADVISORS LLC 579.00K sh · $57.22M
- VESTOR CAPITAL, LLC 1.06M sh · $52.87M
- PERCEPTIVE ADVISORS LLC 345.23K sh · $34.12M
- Rakuten Investment Management, Inc. 311.33K sh · $31.43M
- Y-Intercept (Hong Kong) Ltd 250.72K sh · $24.78M
- Blue Sparrow, LLC /DE 200.00K sh · $19.77M
- LGT Group Foundation 188.44K sh · $18.62M
- Parkman Healthcare Partners LLC 165.18K sh · $16.33M
- NATIONAL FARMERS UNION MUTUAL INSURANCE SOCIETY LIMITED(THE) 163.00K sh · $16.11M
- MANAGED ASSET PORTFOLIOS, LLC 154.62K sh · $15.28M
Fully Exited (vs previous quarter)
- Sixth Street Partners Management Company, L.P. sold 59.67M sh · $5.41B
- GEODE CAPITAL MANAGEMENT, LLC sold 39.22M sh · $3.54B
- Norges Bank Investment Management sold 23.35M sh · $2.12B
- Jupiter Topco LLC sold 8.08M sh · $732.79M
- SG Americas Securities, LLC sold 7.20M sh · $618.00M
- National Pension Service sold 4.21M sh · $381.88M
- Vestal Point Capital, LP sold 1.40M sh · $127.04M
- Freestone Grove Partners LP sold 1.37M sh · $124.57M
- PSP Investments sold 1.37M sh · $124.55M
- ING GROEP NV sold 1.32M sh · $119.81M
- Alyeska Investment Group, L.P. sold 1.18M sh · $106.72M
- JOHNSON INVESTMENT COUNSEL INC sold 986.62K sh · $89.53M
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BlackRock Inc | 151.67M | 152.56M | 106.50K | 146.91M | 141.56M | 141.29M | 136.98M | 136.53M | 131.03M | — | — | — | — | — | — | — | — | — | — | — |
| VANGUARD CAPITAL MANAGEMENT LLC | 113.25M | 113.75M | 112.95M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| STATE STREET CORP | 81.43M | — | 79.58M | 79.85M | 78.23M | 78.35M | 77.66M | 77.17M | 76.72M | 74.40M | 74.74M | 74.69M | 73.23M | — | — | — | — | — | — | — |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 57.16M | 59.67M | 45.50M | 13.19M | 13.14M | 13.18M | 13.09M | 12.94M | 12.61M | 12.62M | 12.37M | 12.36M | 12.15M | — | — | — | — | — | — | — |
| Charles Schwab Investment Management | 57.16M | 59.67M | 45.50M | 13.19M | 13.14M | 13.18M | 13.11M | 12.94M | 12.61M | 12.62M | 12.37M | 12.36M | 12.15M | 12.12M | 12.14M | 12.09M | 11.89M | 11.54M | 11.52M | 11.30M |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 47.94M | 49.02M | 47.94M | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Capital Research Global Investors | 44.98M | 36.91M | 49.78M | 39.17M | 38.77M | 41.77M | 50.73M | 54.10M | 53.30M | 57.24M | 83.98M | 86.59M | 79.06M | — | — | — | — | — | — | — |
| Capital Research Global Investors | 44.98M | 36.91M | 49.78M | 39.17M | 38.77M | 41.77M | 50.73M | 54.10M | 53.30M | 57.24M | 83.98M | 86.59M | 79.06M | 77.23M | 76.40M | 76.79M | 78.81M | 80.10M | 80.68M | 84.13M |
| Geode Capital Management | 39.59M | 39.22M | 39.15M | 38.41M | 38.54M | 38.29M | 36.90M | 35.67M | 34.90M | 34.41M | 33.73M | 32.85M | 32.42M | 31.88M | 31.20M | 30.60M | 30.06M | 29.41M | 28.55M | 27.91M |
| Capital International Investors | 35.46M | 34.65M | 37.50M | 63.23M | 61.61M | 60.14M | 66.82M | 67.97M | 65.74M | 71.80M | 70.18M | 64.29M | 62.84M | — | — | — | — | — | — | — |
| Morgan Stanley | 28.95M | 26.61M | 30.10M | 36.73M | 38.63M | 35.21M | 36.14M | 36.12M | 34.51M | 35.62M | 36.01M | 35.94M | 35.64M | 36.38M | 36.67M | 38.97M | 34.08M | 36.44M | 29.88M | 29.32M |
| Franklin Resources | 20.44M | 18.81M | 20.02M | 11.16M | 10.30M | 9.47M | 9.39M | 10.79M | 9.76M | 8.58M | 8.57M | 8.32M | 8.19M | 8.05M | 8.05M | 9.65M | 10.45M | 10.57M | 10.69M | 10.05M |
| PRICE T ROWE ASSOCIATES INC /MD/ | 23.55M | 22.79M | 17.28M | 14.72M | 15.80M | 10.35M | 4.17M | 3.80M | 4.05M | 4.06M | 4.14M | 4.29M | 4.29M | — | — | — | — | — | — | — |
| T. Rowe Price Associates | 23.55M | 22.79M | 17.28M | 14.72M | 15.80M | 10.35M | 4.17M | 3.80M | 4.05M | 4.06M | 4.14M | 4.29M | 4.29M | 4.32M | 4.11M | 4.28M | 10.23M | 9.41M | 8.34M | 5.67M |
| Bank of America Corp | 18.57M | 17.67M | 19.28M | 19.83M | 104.00K | 176.60K | 138.10K | 73.70K | 8.12M | 227.40K | 6.68M | 254.50K | 84.40K | 17.57M | 20.19M | 22.91M | 22.45M | 24.62M | 24.66M | 25.62M |
| Northern Trust Corp | 17.98M | 18.27M | 19.39M | 19.78M | 20.44M | 21.04M | 21.33M | 22.06M | 20.00M | 20.68M | 21.02M | 21.63M | 23.02M | 22.67M | 23.92M | 24.01M | 24.05M | 24.30M | 25.37M | 25.52M |
| Deutsche Bank AG | 17.69M | 16.71M | 14.09M | 11.58M | 10.64M | 11.01M | 11.28M | 12.42M | 11.50M | 10.71M | 9.68M | 6.81M | 5.58M | 6.02M | 6.33M | 5.18M | 5.45M | 4.71M | 5.02M | 4.83M |
| MFS Investment Management | 14.93M | 13.36M | 15.50M | 14.52M | 15.10M | 14.28M | 14.45M | 12.81M | 13.32M | 10.61M | 10.83M | 12.05M | 13.60M | 18.15M | 21.15M | 24.83M | 24.53M | 25.46M | 25.88M | 26.70M |
| Fidelity Management & Research (FMR) | 14.40M | 13.42M | 10.85M | 9.63M | 11.59M | 13.56M | 10.68M | 9.11M | 9.28M | 9.88M | 7.95M | 7.61M | 6.08M | 6.87M | 7.61M | 9.12M | 10.63M | 12.38M | 12.93M | 14.33M |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | 13.59M | — | — | — | — | — | — | — |
▲ Bought Low (fund opened/added, stock rose ≥5% next quarter) ▼ Sold High (fund reduced, stock fell ≥5% next quarter)
Drag / scroll to zoom · Default shows the most recent year · Annotations come from quarterly fund actions in 13F filings · Hover a marker for details
FAQ
Which funds hold ABT?
As of 2026-Q3, 3054 institutional funds reported holding ABT (ABBOTT LABORATORIES) in SEC 13F filings, with a combined reported value of $136.86B.
How many shares of ABT do institutions own?
13F filers reported 1.38B shares of ABT, worth $136.86B in aggregate at the end of 2026-Q3.
Is institutional ownership of ABT rising or falling?
Share counts moved +1.0% versus the prior quarter — accumulation.
Who are the top institutional holders of ABT?
The largest 13F holders are Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC; the top 25 are ranked at the top of this page.
Who are the major shareholders of ABBOTT LABORATORIES?
The major shareholders of ABBOTT LABORATORIES (ABT) by reported 13F value are Vanguard Group, BlackRock Inc, VANGUARD CAPITAL MANAGEMENT LLC, STATE STREET CORP, CHARLES SCHWAB INVESTMENT MANAGEMENT INC, among 4195 institutional holders.
Which legendary investors own ABT?
7 of the legendary investors tracked on HoldingsHub report ABT (ABBOTT LABORATORIES) in their latest 13F filings, led by Mason Hawkins, Jensen Investment Management, Mairs & Power, David Katz, Dodge & Cox. Each is shown at that manager's own most recent quarter.
Do superinvestors agree on ABT?
7 tracked superinvestors hold ABT simultaneously — see the consensus page for the stocks they own together.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.